Cargando…
Efficacy of neoadjuvant endocrine therapy in patients with poorly differentiated neuroendocrine carcinoma of the breast: A case report
RATIONALE: Poorly differentiated neuroendocrine carcinoma of the breast is a rare cancer with poor prognosis. There is no standard treatment for the disease. Neoadjuvant therapies and surgery are considered to be the main treatment when the tumor diameter is greater than 5.0 cm. Neoadjuvant therapie...
Autores principales: | Zhang, Yonglin, Liu, Chao, Zheng, Chaoting, Ren, Qiaozhen, Wang, Qimin, Gao, Xinyi, He, Yushuang, Wu, Jierong, Chen, Guanglei, Li, Xuelu, Ma, Zhenhai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7581040/ https://www.ncbi.nlm.nih.gov/pubmed/33120755 http://dx.doi.org/10.1097/MD.0000000000022652 |
Ejemplares similares
-
Pancreatic neuroendocrine tumor producing vasopressin: A case report
por: Li, Jingyan, et al.
Publicado: (2021) -
A case report of multiple endocrine neoplasia type 1 and autoimmune disease: Coincidence or correlation?
por: Chaves, Carolina, et al.
Publicado: (2021) -
The correlation between UDP-glucuronosyltransferase polymorphisms and environmental endocrine disruptors levels in polycystic ovary syndrome patients
por: Luo, Yunyao, et al.
Publicado: (2020) -
Different RET gene mutation-induced multiple endocrine neoplasia type 2A in 3 Chinese families
por: Liu, Qiuli, et al.
Publicado: (2017) -
Multiple endocrine neoplasia 2A with RET mutation p.Cys611Tyr: A case report
por: Li, Yan, et al.
Publicado: (2021)